{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T06:01:00Z","timestamp":1788415260201,"version":"build-2803163510"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T00:00:00Z","timestamp":1723593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T00:00:00Z","timestamp":1723593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFA1100903, 2021YFA1100900"],"award-info":[{"award-number":["2021YFA1100903, 2021YFA1100900"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82371736"],"award-info":[{"award-number":["82371736"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Oncol."],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s13402-024-00978-y","type":"journal-article","created":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T08:02:01Z","timestamp":1723622521000},"page":"183-203","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Loss of histone deubiquitinase Bap1 triggers anti-tumor immunity"],"prefix":"10.1007","volume":"48","author":[{"given":"Hong","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingxia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linlin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swee Hoe","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingjie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kairui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhichao","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,14]]},"reference":[{"key":"978_CR1","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/s41571-022-00601-9","volume":"19","author":"H Yamaguchi","year":"2022","unstructured":"H. Yamaguchi, J.M. Hsu, W.H. Yang, M.C. Hung, Mechanisms regulating PD-L1 expression in cancers and associated opportunities for novel small-molecule therapeutics. Nat. Rev. Clin. Oncol. 19, 287\u2013305 (2022). https:\/\/doi.org\/10.1038\/s41571-022-00601-9","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"978_CR2","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.cell.2017.01.017","volume":"168","author":"P Sharma","year":"2017","unstructured":"P. Sharma, S. Hu-Lieskovan, J.A. Wargo, A. Ribas, Primary, adaptive, and Acquired Resistance to Cancer Immunotherapy. Cell. 168, 707\u2013723 (2017). https:\/\/doi.org\/10.1016\/j.cell.2017.01.017","journal-title":"Cell"},{"key":"978_CR3","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.molimm.2017.04.012","volume":"87","author":"J Dunn","year":"2017","unstructured":"J. Dunn, S. Rao, Epigenetics and immunotherapy: the current state of play. Mol. Immunol. 87, 227\u2013239 (2017). https:\/\/doi.org\/10.1016\/j.molimm.2017.04.012","journal-title":"Mol. Immunol."},{"key":"978_CR4","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.coph.2017.05.006","volume":"35","author":"SJ Gallagher","year":"2017","unstructured":"S.J. Gallagher, E. Shklovskaya, P. Hersey, Epigenetic modulation in cancer immunotherapy. Curr. Opin. Pharmacol. 35, 48\u201356 (2017). https:\/\/doi.org\/10.1016\/j.coph.2017.05.006","journal-title":"Curr. Opin. Pharmacol."},{"key":"978_CR5","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/s41573-020-0077-5","volume":"19","author":"SJ Hogg","year":"2020","unstructured":"S.J. Hogg, P.A. Beavis, M.A. Dawson, R.W. Johnstone, Targeting the epigenetic regulation of antitumour immunity. Nat. Rev. Drug Discov. 19, 776\u2013800 (2020). https:\/\/doi.org\/10.1038\/s41573-020-0077-5","journal-title":"Nat. Rev. Drug Discov"},{"key":"978_CR6","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.cell.2018.05.052","volume":"174","author":"W Sheng","year":"2018","unstructured":"W. Sheng, M.W. LaFleur, T.H. Nguyen, S. Chen, A. Chakravarthy, J.R. Conway, Y. Li, H. Chen, H. Yang, P.H. Hsu, E.M. Van Allen, G.J. Freeman, D.D. De Carvalho, H.H. He, A.H. Sharpe, Y. Shi, LSD1 ablation stimulates anti-tumor immunity and enables checkpoint blockade. Cell. 174, 549\u2013563e519 (2018). https:\/\/doi.org\/10.1016\/j.cell.2018.05.052","journal-title":"Cell"},{"key":"978_CR7","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/s41388-018-0451-5","volume":"38","author":"Y Qin","year":"2019","unstructured":"Y. Qin, S.N. Vasilatos, L. Chen, H. Wu, Z. Cao, Y. Fu, M. Huang, A.M. Vlad, B. Lu, S. Oesterreich, N.E. Davidson, Y. Huang, Inhibition of histone lysine-specific demethylase 1 elicits breast tumor immunity and enhances antitumor efficacy of immune checkpoint blockade. Oncogene. 38, 390\u2013405 (2019). https:\/\/doi.org\/10.1038\/s41388-018-0451-5","journal-title":"Oncogene"},{"key":"978_CR8","doi-asserted-by":"publisher","first-page":"6831","DOI":"10.1038\/s41467-021-27179-7","volume":"12","author":"Y Liu","year":"2021","unstructured":"Y. Liu, B. Debo, M. Li, Z. Shi, W. Sheng, Y. Shi, LSD1 inhibition sustains T cell invigoration with a durable response to PD-1 blockade. Nat. Commun. 12, 6831 (2021). https:\/\/doi.org\/10.1038\/s41467-021-27179-7","journal-title":"Nat. Commun."},{"key":"978_CR9","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/j.celrep.2016.09.079","volume":"17","author":"K Tzelepis","year":"2016","unstructured":"K. Tzelepis, H. Koike-Yusa, E. De Braekeleer, Y. Li, E. Metzakopian, O.M. Dovey, A. Mupo, V. Grinkevich, M. Li, M. Mazan, M. Gozdecka, S. Ohnishi, J. Cooper, M. Patel, T. McKerrell, B. Chen, A.F. Domingues, P. Gallipoli, S. Teichmann, H. Ponstingl, U. McDermott, J. Saez-Rodriguez, B.J.P. Huntly, F. Iorio, C. Pina, G.S. Vassiliou, K. Yusa, A CRISPR dropout screen identifies genetic vulnerabilities and therapeutic targets in Acute myeloid leukemia. Cell. Rep. 17, 1193\u20131205 (2016). https:\/\/doi.org\/10.1016\/j.celrep.2016.09.079","journal-title":"Cell. Rep."},{"key":"978_CR10","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/nbt.2800","volume":"32","author":"H Koike-Yusa","year":"2014","unstructured":"H. Koike-Yusa, Y. Li, E.P. Tan, C. Velasco-Herrera Mdel, K. Yusa, Genome-wide recessive genetic screening in mammalian cells with a lentiviral CRISPR-guide RNA library. Nat. Biotechnol. 32, 267\u2013273 (2014). https:\/\/doi.org\/10.1038\/nbt.2800","journal-title":"Nat. Biotechnol."},{"key":"978_CR11","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1186\/s13059-014-0554-4","volume":"15","author":"W Li","year":"2014","unstructured":"W. Li, H. Xu, T. Xiao, L. Cong, M.I. Love, F. Zhang, R.A. Irizarry, J.S. Liu, M. Brown, X.S. Liu, MAGeCK enables robust identification of essential genes from genome-scale CRISPR\/Cas9 knockout screens. Genome Biol. 15, 554 (2014). https:\/\/doi.org\/10.1186\/s13059-014-0554-4","journal-title":"Genome Biol."},{"key":"978_CR12","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/s41592-020-0825-9","volume":"17","author":"Z Miao","year":"2020","unstructured":"Z. Miao, P. Moreno, N. Huang, I. Papatheodorou, A. Brazma, S.A. Teichmann, Putative cell type discovery from single-cell gene expression data. Nat. Methods. 17, 621\u2013628 (2020). https:\/\/doi.org\/10.1038\/s41592-020-0825-9","journal-title":"Nat. Methods"},{"key":"978_CR13","doi-asserted-by":"publisher","first-page":"3875","DOI":"10.1182\/blood-2010-01-265041","volume":"116","author":"JN Kochenderfer","year":"2010","unstructured":"J.N. Kochenderfer, Z. Yu, D. Frasheri, N.P. Restifo, S.A. Rosenberg, Adoptive transfer of syngeneic T cells transduced with a chimeric antigen receptor that recognizes murine CD19 can eradicate lymphoma and normal B cells. Blood. 116, 3875\u20133886 (2010). https:\/\/doi.org\/10.1182\/blood-2010-01-265041","journal-title":"Blood"},{"key":"978_CR14","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1084\/jem.20160801","volume":"214","author":"VR Juneja","year":"2017","unstructured":"V.R. Juneja, K.A. McGuire, R.T. Manguso, M.W. LaFleur, N. Collins, W.N. Haining, G.J. Freeman, A.H. Sharpe, PD-L1 on tumor cells is sufficient for immune evasion in immunogenic tumors and inhibits CD8 T cell cytotoxicity. J. Exp. Med. 214, 895\u2013904 (2017). https:\/\/doi.org\/10.1084\/jem.20160801","journal-title":"J. Exp. Med."},{"key":"978_CR15","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.celrep.2018.06.027","volume":"24","author":"M Li","year":"2018","unstructured":"M. Li, J.S.L. Yu, K. Tilgner, S.H. Ong, H. Koike-Yusa, K. Yusa, Genome-wide CRISPR-KO screen uncovers mTORC1-Mediated Gsk3 regulation in naive pluripotency maintenance and dissolution. Cell. Rep. 24, 489\u2013502 (2018). https:\/\/doi.org\/10.1016\/j.celrep.2018.06.027","journal-title":"Cell. Rep."},{"key":"978_CR16","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ymeth.2019.04.015","volume":"164\u2013165","author":"JSL Yu","year":"2019","unstructured":"J.S.L. Yu, K. Yusa, Genome-wide CRISPR-Cas9 screening in mammalian cells. Methods. 164\u2013165, 29\u201335 (2019). https:\/\/doi.org\/10.1016\/j.ymeth.2019.04.015","journal-title":"Methods"},{"key":"978_CR17","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/nature08966","volume":"465","author":"JC Scheuermann","year":"2010","unstructured":"J.C. Scheuermann, A.G. de Ayala Alonso, K. Oktaba, N. Ly-Hartig, R.K. McGinty, S. Fraterman, M. Wilm, T.W. Muir, J. Muller, Histone H2A deubiquitinase activity of the polycomb repressive complex PR-DUB. Nature. 465, 243\u2013247 (2010). https:\/\/doi.org\/10.1038\/nature08966","journal-title":"Nature"},{"key":"978_CR18","doi-asserted-by":"publisher","first-page":"6953","DOI":"10.1158\/0008-5472.CAN-08-0365","volume":"68","author":"KH Ventii","year":"2008","unstructured":"K.H. Ventii, N.S. Devi, K.L. Friedrich, T.A. Chernova, M. Tighiouart, E.G. Van Meir, K.D. Wilkinson, BRCA1-associated protein-1 is a tumor suppressor that requires deubiquitinating activity and nuclear localization. Cancer Res. 68, 6953\u20136962 (2008). https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-0365","journal-title":"Cancer Res."},{"key":"978_CR19","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1093\/jmcb\/mjw051","volume":"9","author":"MA Suico","year":"2017","unstructured":"M.A. Suico, T. Shuto, H. Kai, Roles and regulations of the ETS transcription factor ELF4\/MEF. J. Mol. Cell. Biol. 9, 168\u2013177 (2017). https:\/\/doi.org\/10.1093\/jmcb\/mjw051","journal-title":"J. Mol. Cell. Biol."},{"key":"978_CR20","doi-asserted-by":"publisher","first-page":"D165","DOI":"10.1093\/nar\/gkab1113","volume":"50","author":"JA Castro-Mondragon","year":"2022","unstructured":"J.A. Castro-Mondragon, R. Riudavets-Puig, I. Rauluseviciute, R.B. Lemma, L. Turchi, R. Blanc-Mathieu, J. Lucas, P. Boddie, A. Khan, N. Manosalva Perez, O. Fornes, T.Y. Leung, A. Aguirre, F. Hammal, D. Schmelter, D. Baranasic, B. Ballester, A. Sandelin, B. Lenhard, K. Vandepoele, W.W. Wasserman, F. Parcy, A. Mathelier, JASPAR 2022: the 9th release of the open-access database of transcription factor binding profiles. Nucleic Acids Res. 50, D165\u2013D173 (2022). https:\/\/doi.org\/10.1093\/nar\/gkab1113","journal-title":"Nucleic Acids Res."},{"key":"978_CR21","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.celrep.2017.04.031","volume":"19","author":"A Garcia-Diaz","year":"2017","unstructured":"A. Garcia-Diaz, D.S. Shin, B.H. Moreno, J. Saco, H. Escuin-Ordinas, G.A. Rodriguez, J.M. Zaretsky, L. Sun, W. Hugo, X. Wang, G. Parisi, C.P. Saus, D.Y. Torrejon, T.G. Graeber, B. Comin-Anduix, S. Hu-Lieskovan, R. Damoiseaux, R.S. Lo, Ribas, Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression. Cell. Rep. 19, 1189\u20131201 (2017). https:\/\/doi.org\/10.1016\/j.celrep.2017.04.031","journal-title":"Cell. Rep."},{"key":"978_CR22","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1126\/science.1164206","volume":"322","author":"K Hildner","year":"2008","unstructured":"K. Hildner, B.T. Edelson, W.E. Purtha, M. Diamond, H. Matsushita, M. Kohyama, B. Calderon, B.U. Schraml, E.R. Unanue, M.S. Diamond, R.D. Schreiber, T.L. Murphy, K.M. Murphy, Batf3 deficiency reveals a critical role for CD8alpha\u2009+\u2009dendritic cells in cytotoxic T cell immunity. Science. 322, 1097\u20131100 (2008). https:\/\/doi.org\/10.1126\/science.1164206","journal-title":"Science"},{"key":"978_CR23","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1146\/annurev.cellbio.24.110707.175347","volume":"24","author":"DR Peaper","year":"2008","unstructured":"D.R. Peaper, P. Cresswell, Regulation of MHC class I assembly and peptide binding. Annu. Rev. Cell. Dev. Biol. 24, 343\u2013368 (2008). https:\/\/doi.org\/10.1146\/annurev.cellbio.24.110707.175347","journal-title":"Annu. Rev. Cell. Dev. Biol."},{"key":"978_CR24","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/s41577-018-0009-3","volume":"18","author":"P Golstein","year":"2018","unstructured":"P. Golstein, G.M. Griffiths, An early history of T cell-mediated cytotoxicity. Nat. Rev. Immunol. 18, 527\u2013535 (2018). https:\/\/doi.org\/10.1038\/s41577-018-0009-3","journal-title":"Nat. Rev. Immunol."},{"key":"978_CR25","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/369031a0","volume":"369","author":"D K\u00e4gi","year":"1994","unstructured":"D. K\u00e4gi, B. Ledermann, K. B\u00fcrki, P. Seiler, B. Odermatt, K.J. Olsen, E.R. Podack, R.M. Zinkernagel, H. Hengartner, Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature. 369, 31\u201337 (1994). https:\/\/doi.org\/10.1038\/369031a0","journal-title":"Nature"},{"key":"978_CR26","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/s41467-018-08255-x","volume":"10","author":"A Campagne","year":"2019","unstructured":"A. Campagne, M.K. Lee, D. Zielinski, A. Michaud, S. Le Corre, F. Dingli, H. Chen, L.Z. Shahidian, I. Vassilev, N. Servant, D. Loew, E. Pasmant, S. Postel-Vinay, M. Wassef, R. Margueron, BAP1 complex promotes transcription by opposing PRC1-mediated H2A ubiquitylation. Nat. Commun. 10, 348 (2019). https:\/\/doi.org\/10.1038\/s41467-018-08255-x","journal-title":"Nat. Commun."},{"key":"978_CR27","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1101\/gad.347005.120","volume":"35","author":"NA Fursova","year":"2021","unstructured":"N.A. Fursova, A.H. Turberfield, N.P. Blackledge, E.L. Findlater, A. Lastuvkova, M.K. Huseyin, P. Dobrinic, R.J. Klose, BAP1 constrains pervasive H2AK119ub1 to control the transcriptional potential of the genome. Genes Dev. 35, 749\u2013770 (2021). https:\/\/doi.org\/10.1101\/gad.347005.120","journal-title":"Genes Dev."},{"key":"978_CR28","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/s41556-018-0178-0","volume":"20","author":"Y Zhang","year":"2018","unstructured":"Y. Zhang, J. Shi, X. Liu, L. Feng, Z. Gong, P. Koppula, K. Sirohi, X. Li, Y. Wei, H. Lee, L. Zhuang, G. Chen, Z.D. Xiao, M.C. Hung, J. Chen, P. Huang, W. Li, B. Gan, BAP1 links metabolic regulation of ferroptosis to tumour suppression. Nat. Cell. Biol. 20, 1181\u20131192 (2018). https:\/\/doi.org\/10.1038\/s41556-018-0178-0","journal-title":"Nat. Cell. Biol."},{"key":"978_CR29","doi-asserted-by":"publisher","first-page":"6119","DOI":"10.1038\/s41467-020-19973-6","volume":"11","author":"M Zhang","year":"2020","unstructured":"M. Zhang, W. Yang, P. Wang, Y. Deng, Y.T. Dong, F.F. Liu, R. Huang, P. Zhang, Y.Q. Duan, X.D. Liu, D. Lin, Q. Chu, B. Zhong, CCL7 recruits cDC1 to promote antitumor immunity and facilitate checkpoint immunotherapy to non-small cell lung cancer. Nat. Commun. 11, 6119 (2020). https:\/\/doi.org\/10.1038\/s41467-020-19973-6","journal-title":"Nat. Commun."},{"key":"978_CR30","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s40425-019-0511-6","volume":"7","author":"Q Gao","year":"2019","unstructured":"Q. Gao, S. Wang, X. Chen, S. Cheng, Z. Zhang, F. Li, L. Huang, Y. Yang, B. Zhou, D. Yue, D. Wang, L. Cao, N.R. Maimela, B. Zhang, J. Yu, L. Wang, Y. Zhang, Cancer-cell-secreted CXCL11 promoted CD8(+) T cells infiltration through docetaxel-induced-release of HMGB1 in NSCLC. J. Immunother Cancer. 7, 42 (2019). https:\/\/doi.org\/10.1186\/s40425-019-0511-6","journal-title":"J. Immunother Cancer"},{"key":"978_CR31","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1158\/2326-6066.CIR-16-0188","volume":"4","author":"T Chao","year":"2016","unstructured":"T. Chao, E.E. Furth, R.H. Vonderheide, CXCR2-Dependent Accumulation of Tumor-Associated neutrophils regulates T-cell immunity in pancreatic ductal adenocarcinoma. Cancer Immunol. Res. 4, 968\u2013982 (2016). https:\/\/doi.org\/10.1158\/2326-6066.CIR-16-0188","journal-title":"Cancer Immunol. Res."},{"key":"978_CR32","doi-asserted-by":"publisher","first-page":"3127","DOI":"10.1172\/JCI61067","volume":"122","author":"T Jamieson","year":"2012","unstructured":"T. Jamieson, M. Clarke, C.W. Steele, M.S. Samuel, J. Neumann, A. Jung, D. Huels, M.F. Olson, S. Das, R.J. Nibbs, O.J. Sansom, Inhibition of CXCR2 profoundly suppresses inflammation-driven and spontaneous tumorigenesis. J. Clin. Invest. 122, 3127\u20133144 (2012). https:\/\/doi.org\/10.1172\/JCI61067","journal-title":"J. Clin. Invest."},{"key":"978_CR33","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nature25501","volume":"554","author":"S Mariathasan","year":"2018","unstructured":"S. Mariathasan, S.J. Turley, D. Nickles, A. Castiglioni, K. Yuen, Y. Wang, E.E. III Kadel, H. Koeppen, J.L. Astarita, R. Cubas, S. Jhunjhunwala, R. Banchereau, Y. Yang, Y. Guan, C. Chalouni, J. Ziai, Y. Senbabaoglu, S. Santoro, D. Sheinson, J. Hung, J.M. Giltnane, A.A. Pierce, K. Mesh, S. Lianoglou, J. Riegler, R.A.D. Carano, P. Eriksson, M. Hoglund, L. Somarriba, D.L. Halligan, M.S. van der Heijden, Y. Loriot, J.E. Rosenberg, L. Fong, I. Mellman, D.S. Chen, M. Green, C. Derleth, G.D. Fine, P.S. Hegde, R. Bourgon, T. Powles, TGFbeta attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells. Nature. 554, 544\u2013548 (2018). https:\/\/doi.org\/10.1038\/nature25501","journal-title":"Nature"},{"key":"978_CR34","doi-asserted-by":"publisher","first-page":"3594","DOI":"10.1172\/jci127755","volume":"129","author":"N Markosyan","year":"2019","unstructured":"N. Markosyan, J. Li, Y.H. Sun, L.P. Richman, J.H. Lin, F. Yan, L. Quinones, Y. Sela, T. Yamazoe, N. Gordon, J.W. Tobias, K.T. Byrne, A.J. Rech, G.A. FitzGerald, B.Z. Stanger, R.H. Vonderheide, Tumor cell-intrinsic EPHA2 suppresses anti-tumor immunity by regulating PTGS2 (COX-2). J. Clin. Invest. 129, 3594\u20133609 (2019). https:\/\/doi.org\/10.1172\/jci127755","journal-title":"J. Clin. Invest."},{"key":"978_CR35","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1096\/fj.05-4038fje","volume":"19","author":"DM Brantley-Sieders","year":"2005","unstructured":"D.M. Brantley-Sieders, W.B. Fang, D.J. Hicks, G. Zhuang, Y. Shyr, J. Chen, Impaired tumor microenvironment in EphA2-deficient mice inhibits tumor angiogenesis and metastatic progression. Faseb j. 19, 1884\u20131886 (2005). https:\/\/doi.org\/10.1096\/fj.05-4038fje","journal-title":"Faseb j."},{"key":"978_CR36","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1038\/sj.onc.1208287","volume":"24","author":"K Iwatsuki","year":"2005","unstructured":"K. Iwatsuki, K. Tanaka, T. Kaneko, R. Kazama, S. Okamoto, Y. Nakayama, Y. Ito, M. Satake, S. Takahashi, A. Miyajima, T. Watanabe, T. Hara, Runx1 promotes angiogenesis by downregulation of insulin-like growth factor-binding protein-3. Oncogene. 24, 1129\u20131137 (2005). https:\/\/doi.org\/10.1038\/sj.onc.1208287","journal-title":"Oncogene"},{"key":"978_CR37","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1083\/jcb.140.2.419","volume":"140","author":"TR Kyriakides","year":"1998","unstructured":"T.R. Kyriakides, Y.H. Zhu, L.T. Smith, S.D. Bain, Z. Yang, M.T. Lin, K.G. Danielson, R.V. Iozzo, M. LaMarca, C.E. McKinney, E.I. Ginns, P. Bornstein, Mice that lack thrombospondin 2 display connective tissue abnormalities that are associated with disordered collagen fibrillogenesis, an increased vascular density, and a bleeding diathesis. J. Cell. Biol. 140, 419\u2013430 (1998). https:\/\/doi.org\/10.1083\/jcb.140.2.419","journal-title":"J. Cell. Biol."},{"key":"978_CR38","doi-asserted-by":"publisher","first-page":"4449","DOI":"10.1073\/pnas.96.8.4449","volume":"96","author":"TR Kyriakides","year":"1999","unstructured":"T.R. Kyriakides, K.J. Leach, A.S. Hoffman, B.D. Ratner, P. Bornstein, Mice that lack the angiogenesis inhibitor, thrombospondin 2, mount an altered foreign body reaction characterized by increased vascularity. Proc. Natl. Acad. Sci. U S A 96, 4449\u20134454 (1999). https:\/\/doi.org\/10.1073\/pnas.96.8.4449","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"978_CR39","doi-asserted-by":"publisher","first-page":"14888","DOI":"10.1073\/pnas.96.26.14888","volume":"96","author":"M Streit","year":"1999","unstructured":"M. Streit, L. Riccardi, P. Velasco, L.F. Brown, T. Hawighorst, P. Bornstein, M. Detmar, Thrombospondin-2: a potent endogenous inhibitor of tumor growth and angiogenesis. Proc. Natl. Acad. Sci. U S A 96, 14888\u201314893 (1999). https:\/\/doi.org\/10.1073\/pnas.96.26.14888","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"978_CR40","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.preghy.2020.05.009","volume":"21","author":"X Dai","year":"2020","unstructured":"X. Dai, Y. Fu, Y. Ye, Increased NDRG1 expression suppresses angiogenesis via PI3K\/AKT pathway in human placental cells. Pregnancy Hypertens. 21, 106\u2013110 (2020). https:\/\/doi.org\/10.1016\/j.preghy.2020.05.009","journal-title":"Pregnancy Hypertens."},{"key":"978_CR41","doi-asserted-by":"publisher","unstructured":"B.J. Hwang, L.C. Tsao, C.R. Acharya, T. Trotter, P. Agarwal, J. Wei, T. Wang, X.Y. Yang, G. Lei, T. Osada, H.K. Lyerly, M.A. Morse, Z.C. Hartman, Sensitizing immune unresponsive colorectal cancers to immune checkpoint inhibitors through MAVS overexpression. J. Immunother Cancer. 10 (2022). https:\/\/doi.org\/10.1136\/jitc-2021-003721","DOI":"10.1136\/jitc-2021-003721"},{"key":"978_CR42","doi-asserted-by":"publisher","first-page":"e111112","DOI":"10.15252\/embj.2022111112","volume":"42","author":"X She","year":"2023","unstructured":"X. She, S. Shen, G. Chen, Y. Gao, J. Ma, Y. Gao, Y. Liu, G. Gao, Y. Zhao, C. Wang, C. Jiang, P. Wang, H. Qin, H. Gao, Immune surveillance of brain metastatic cancer cells is mediated by IFITM1. EMBO J. 42, e111112 (2023). https:\/\/doi.org\/10.15252\/embj.2022111112","journal-title":"EMBO J."},{"key":"978_CR43","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/978-1-0716-0327-7_19","volume":"2120","author":"D Aran","year":"2020","unstructured":"D. Aran, Cell-type Enrichment Analysis of Bulk transcriptomes using xCell. Methods Mol. Biol. 2120, 263\u2013276 (2020). https:\/\/doi.org\/10.1007\/978-1-0716-0327-7_19","journal-title":"Methods Mol. Biol."},{"key":"978_CR44","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1158\/2159-8290.CD-19-1220","volume":"10","author":"M Carbone","year":"2020","unstructured":"M. Carbone, J.W. Harbour, J. Brugarolas, A. Bononi, I. Pagano, A. Dey, T. Krausz, H.I. Pass, H. Yang, G. Gaudino, Biological mechanisms and clinical significance of BAP1 mutations in Human Cancer. Cancer Discov. 10, 1103\u20131120 (2020). https:\/\/doi.org\/10.1158\/2159-8290.CD-19-1220","journal-title":"Cancer Discov"},{"key":"978_CR45","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1126\/science.1194472","volume":"330","author":"JW Harbour","year":"2010","unstructured":"J.W. Harbour, M.D. Onken, E.D. Roberson, S. Duan, L. Cao, L.A. Worley, M.L. Council, K.A. Matatall, C. Helms, A.M. Bowcock, Frequent mutation of BAP1 in metastasizing uveal melanomas. Science. 330, 1410\u20131413 (2010). https:\/\/doi.org\/10.1126\/science.1194472","journal-title":"Science"},{"key":"978_CR46","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/ng.855","volume":"43","author":"M Bott","year":"2011","unstructured":"M. Bott, M. Brevet, B.S. Taylor, S. Shimizu, T. Ito, L. Wang, J. Creaney, R.A. Lake, M.F. Zakowski, B. Reva, C. Sander, R. Delsite, S. Powell, Q. Zhou, R. Shen, A. Olshen, V. Rusch, M. Ladanyi, The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma. Nat. Genet. 43, 668\u2013672 (2011). https:\/\/doi.org\/10.1038\/ng.855","journal-title":"Nat. Genet."},{"key":"978_CR47","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1038\/ng.912","volume":"43","author":"JR Testa","year":"2011","unstructured":"J.R. Testa, M. Cheung, J. Pei, J.E. Below, Y. Tan, E. Sementino, N.J. Cox, A.U. Dogan, H.I. Pass, S. Trusa, M. Hesdorffer, M. Nasu, A. Powers, Z. Rivera, S. Comertpay, M. Tanji, G. Gaudino, H. Yang, M. Carbone, Germline BAP1 mutations predispose to malignant mesothelioma. Nat. Genet. 43, 1022\u20131025 (2011). https:\/\/doi.org\/10.1038\/ng.912","journal-title":"Nat. Genet."},{"key":"978_CR48","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1097\/jto.0000000000000471","volume":"10","author":"M Nasu","year":"2015","unstructured":"M. Nasu, M. Emi, S. Pastorino, M. Tanji, A. Powers, H. Luk, F. Baumann, Y.A. Zhang, A. Gazdar, S. Kanodia, M. Tiirikainen, E. Flores, G. Gaudino, M.J. Becich, H.I. Pass, H. Yang, M. Carbone, High incidence of somatic BAP1 alterations in sporadic malignant mesothelioma. J. Thorac. Oncol. 10, 565\u2013576 (2015). https:\/\/doi.org\/10.1097\/jto.0000000000000471","journal-title":"J. Thorac. Oncol."},{"key":"978_CR49","doi-asserted-by":"publisher","first-page":"JCO2018790352","DOI":"10.1200\/JCO.2018.79.0352","volume":"36","author":"S Pastorino","year":"2018","unstructured":"S. Pastorino, Y. Yoshikawa, H.I. Pass, M. Emi, M. Nasu, I. Pagano, Y. Takinishi, R. Yamamoto, M. Minaai, T. Hashimoto-Tamaoki, M. Ohmuraya, K. Goto, C. Goparaju, K.Y. Sarin, M. Tanji, A. Bononi, A. Napolitano, G. Gaudino, M. Hesdorffer, H. Yang, M. Carbone, A subset of Mesotheliomas with Improved Survival Occurring in carriers of BAP1 and other germline mutations. J. Clin. Oncol. 36, JCO2018790352 (2018). https:\/\/doi.org\/10.1200\/JCO.2018.79.0352","journal-title":"J. Clin. Oncol."},{"key":"978_CR50","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1093\/carcin\/bgu227","volume":"36","author":"F Baumann","year":"2015","unstructured":"F. Baumann, E. Flores, A. Napolitano, S. Kanodia, E. Taioli, H. Pass, H. Yang, M. Carbone, Mesothelioma patients with germline BAP1 mutations have 7-fold improved long-term survival. Carcinogenesis. 36, 76\u201381 (2015). https:\/\/doi.org\/10.1093\/carcin\/bgu227","journal-title":"Carcinogenesis"},{"key":"978_CR51","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13073-019-0631-0","volume":"11","author":"M Ladanyi","year":"2019","unstructured":"M. Ladanyi, F. Sanchez Vega, M. Zauderer, Loss of BAP1 as a candidate predictive biomarker for immunotherapy of mesothelioma. Genome Med. 11, 18 (2019). https:\/\/doi.org\/10.1186\/s13073-019-0631-0","journal-title":"Genome Med."},{"key":"978_CR52","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13073-019-0620-3","volume":"11","author":"R Shrestha","year":"2019","unstructured":"R. Shrestha, N. Nabavi, Y.Y. Lin, F. Mo, S. Anderson, S. Volik, H.H. Adomat, D. Lin, H. Xue, X. Dong, R. Shukin, R.H. Bell, B. McConeghy, A. Haegert, S. Brahmbhatt, E. Li, H.Z. Oo, A. Hurtado-Coll, L. Fazli, J. Zhou, Y. McConnell, A. McCart, A. Lowy, G.B. Morin, T. Chen, M. Daugaard, S.C. Sahinalp, F. Hach, S. Le Bihan, M.E. Gleave, Y. Wang, A. Churg, C.C. Collins, BAP1 haploinsufficiency predicts a distinct immunogenic class of malignant peritoneal mesothelioma. Genome Med. 11, 8 (2019). https:\/\/doi.org\/10.1186\/s13073-019-0620-3","journal-title":"Genome Med."},{"key":"978_CR53","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrclinonc.2018.29","volume":"15","author":"D Fukumura","year":"2018","unstructured":"D. Fukumura, J. Kloepper, Z. Amoozgar, D.G. Duda, R.K. Jain, Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges. Nat. Rev. Clin. Oncol. 15, 325\u2013340 (2018). https:\/\/doi.org\/10.1038\/nrclinonc.2018.29","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"978_CR54","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1007\/s00262-008-0524-3","volume":"57","author":"AW Griffioen","year":"2008","unstructured":"A.W. Griffioen, Anti-angiogenesis: making the tumor vulnerable to the immune system. Cancer Immunol. Immunother. 57, 1553\u20131558 (2008). https:\/\/doi.org\/10.1007\/s00262-008-0524-3","journal-title":"Cancer Immunol. Immunother"},{"key":"978_CR55","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1007\/s00262-023-03424-4","volume":"72","author":"K Liu","year":"2023","unstructured":"K. Liu, Y. Huang, Y. Xu, G. Wang, S. Cai, X. Zhang, T. Shi, BAP1-related signature predicts benefits from immunotherapy over VEGFR\/mTOR inhibitors in ccRCC: a retrospective analysis of JAVELIN renal 101 and checkmate-009\/010\/025 trials. Cancer Immunol. Immunother. 72, 2557\u20132572 (2023). https:\/\/doi.org\/10.1007\/s00262-023-03424-4","journal-title":"Cancer Immunol. Immunother"},{"key":"978_CR56","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.immuni.2018.11.014","volume":"50","author":"S Kurtulus","year":"2019","unstructured":"S. Kurtulus, A. Madi, G. Escobar, M. Klapholz, J. Nyman, E. Christian, M. Pawlak, D. Dionne, J. Xia, O. Rozenblatt-Rosen, V.K. Kuchroo, A. Regev, A.C. Anderson, Checkpoint blockade immunotherapy induces dynamic changes in PD-1(-)CD8(+) tumor-infiltrating T cells. Immunity. 50, 181\u2013194e186 (2019). https:\/\/doi.org\/10.1016\/j.immuni.2018.11.014","journal-title":"Immunity"}],"container-title":["Cellular Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-024-00978-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13402-024-00978-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-024-00978-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T11:26:17Z","timestamp":1740396377000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13402-024-00978-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,14]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["978"],"URL":"https:\/\/doi.org\/10.1007\/s13402-024-00978-y","relation":{},"ISSN":["2211-3428","2211-3436"],"issn-type":[{"value":"2211-3428","type":"print"},{"value":"2211-3436","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,14]]},"assertion":[{"value":"26 July 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the mice used in this study were accommodated in the Tongji University animal care facility and were maintained under pathogen-free conditions. All the experiments were approved and conducted following the guidelines of the Animal Care Committee of Tongji University under approval number TJAB03420101.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The results\/data\/figures in this manuscript have not been published elsewhere, nor are they under consideration by another publisher.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Dual publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}